- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MWZ: 4-[3-methyl-1-[4-[4-(2-phenylethyl)-1,3-thiazol-2-yl]-3-(2-piperidin-4-ylethoxy)phenyl]-1,2,3-triazol-3-ium-4-yl]butan-1-amine(Non-covalent)
- 12 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 1 residues within 4Å:- Chain A: R.4
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.4
SO4.3: 3 residues within 4Å:- Chain A: Y.222, R.223, R.229
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Y.222
- Salt bridges: A:R.223, A:R.229
SO4.4: 3 residues within 4Å:- Chain A: R.229, G.230, R.236
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:G.230
- Salt bridges: A:R.229, A:R.236
SO4.5: 4 residues within 4Å:- Chain A: R.249, R.251, T.275, E.277
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:T.275, A:E.277
- Salt bridges: A:R.249, A:R.251
SO4.6: 4 residues within 4Å:- Chain A: Q.38, A.39, T.40, M.125
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:A.39, A:T.40, A:T.40
SO4.7: 3 residues within 4Å:- Chain A: S.471, R.473, T.474
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.473, A:R.473, A:T.474, A:T.474
SO4.13: 1 residues within 4Å:- Chain B: R.4
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:R.4
SO4.14: 3 residues within 4Å:- Chain B: Y.222, R.223, R.229
2 PLIP interactions:2 interactions with chain B- Salt bridges: B:R.223, B:R.229
SO4.15: 3 residues within 4Å:- Chain B: R.229, G.230, R.236
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:G.230
- Salt bridges: B:R.229, B:R.236
SO4.16: 4 residues within 4Å:- Chain B: R.249, R.251, T.275, E.277
2 PLIP interactions:2 interactions with chain B- Salt bridges: B:R.249, B:R.251
SO4.17: 4 residues within 4Å:- Chain B: Q.38, A.39, T.40, M.125
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:A.39, B:T.40, B:T.40
SO4.18: 3 residues within 4Å:- Chain B: S.471, R.473, T.474
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.473, B:R.473, B:T.474
- 4 x GOL: GLYCEROL(Non-functional Binders)
GOL.8: 6 residues within 4Å:- Chain A: P.1, M.2, S.3, R.4, D.7, E.155
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.3, A:R.4, A:D.7
GOL.9: 7 residues within 4Å:- Chain A: G.198, Y.199, I.200, A.285, I.286, G.287, R.288
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:Y.199, A:I.200, A:A.201, A:A.285, A:G.287
GOL.19: 6 residues within 4Å:- Chain B: P.1, M.2, S.3, R.4, D.7, E.155
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.3, B:R.4, B:D.7
GOL.20: 7 residues within 4Å:- Chain B: G.198, Y.199, I.200, A.285, I.286, G.287, R.288
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:Y.199, B:I.200, B:A.201, B:A.285, B:G.287
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.10: 36 residues within 4Å:- Chain A: G.12, G.14, S.15, G.16, V.35, D.36, V.37, A.47, A.48, G.51, T.52, C.53, V.56, G.57, C.58, K.61, G.126, F.127, G.128, A.160, T.161, G.162, Y.199, I.200, R.288, R.291, L.295, G.327, D.328, M.334, L.335, T.336, P.337, A.339
- Chain B: H.462, P.463
26 PLIP interactions:25 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:T.52, A:K.61, A:I.200
- Hydrogen bonds: A:A.13, A:S.15, A:S.15, A:G.16, A:A.48, A:A.48, A:T.52, A:T.52, A:T.52, A:C.53, A:K.61, A:G.128, A:G.128, A:Y.199, A:R.291, A:D.328, A:M.334, A:T.336, A:T.336, B:H.462
- Water bridges: A:G.14, A:D.328
- pi-Stacking: A:Y.199
FAD.21: 36 residues within 4Å:- Chain A: H.462, P.463
- Chain B: G.12, G.14, S.15, G.16, V.35, D.36, V.37, A.47, A.48, G.51, T.52, C.53, V.56, G.57, C.58, K.61, G.126, F.127, G.128, A.160, T.161, G.162, Y.199, I.200, R.288, R.291, L.295, G.327, D.328, M.334, L.335, T.336, P.337, A.339
26 PLIP interactions:25 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:T.52, B:K.61, B:I.200
- Hydrogen bonds: B:A.13, B:S.15, B:S.15, B:G.16, B:A.48, B:A.48, B:T.52, B:T.52, B:C.53, B:K.61, B:G.128, B:G.128, B:R.291, B:D.328, B:M.334, B:T.336, B:T.336, B:T.336, A:H.462
- Water bridges: B:G.14, B:T.52, B:T.52
- pi-Stacking: B:Y.199
- 2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- de Lucio, H. et al., Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity. Eur.J.Med.Chem. (2022)
- Release Date
- 2020-11-18
- Peptides
- Trypanothione reductase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MWZ: 4-[3-methyl-1-[4-[4-(2-phenylethyl)-1,3-thiazol-2-yl]-3-(2-piperidin-4-ylethoxy)phenyl]-1,2,3-triazol-3-ium-4-yl]butan-1-amine(Non-covalent)
- 12 x SO4: SULFATE ION(Non-functional Binders)
- 4 x GOL: GLYCEROL(Non-functional Binders)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- de Lucio, H. et al., Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity. Eur.J.Med.Chem. (2022)
- Release Date
- 2020-11-18
- Peptides
- Trypanothione reductase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A